Skip to main content
. 2016 Sep 19;160(1):163–172. doi: 10.1007/s10549-016-3984-8

Fig. 3.

Fig. 3

Kaplan–Meier curves for disease-free survival between young adult (<35 years; red line), middle-aged adult (35–50 years; blue line), and older adult (>50 years; green line) patients with a HER2-negative/ER-positive, b HER2-positive/ER-positive, c HER2-positive/ER-negative, and d triple receptor negative breast cancer. P-values were calculated using a log-rank test